Wij zijn onze website aan het vernieuwen.

Ontdekt u nog een pagina die niet klopt of hebt u een goede suggestie, laat het ons dan weten via webmedia@umcutrecht.nl.

Deze website maakt gebruik van cookies

Deze website toont video’s van o.a. YouTube. Dergelijke partijen plaatsen cookies (third party cookies). Als u deze cookies niet wilt kunt u dat hier aangeven. Lees meer over het cookiebeleid.

Publications Stroke

Here you can find some of the top publications from our research team

MASH-2 Study Group. Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomised placebo-controlled trial. Dorhout Mees SM et al. Lancet. 2012 Jul 7;380(9836):44-9.

Diabetes, hyperglycaemia, and acute ischaemic stroke. Luitse MJ et al. Lancet Neurol. 2012;11:261-71.

Prevalence of unruptured intracranial aneurysms, with emphasis on sex, age, comorbidity, country, and time period: a systematic review and meta-analysis. Vlak MH et al. Lancet Neurol. 2011 Jul;10(7):626-36.

Long-term outcomes of patients with aneurysmal subarachnoid haemorrhage. Rinkel GJ & Algra A. Lancet Neurol. 2011 Apr;10(4):349-56.

Limb-shaking transient ischaemic attacks in patients with internal carotid artery occlusion: a case-control study. Persoon S et al. Brain. 2010;133:915-22. 

Haemodynamic stroke: clinical features, prognosis, and management. Klijn CJ & Kappelle LJ. Lancet Neurol. 2010;9:1008-17.

Genome-wide association study of intracranial aneurysm identifies three new risk loci. Yasuno K et al. Nat Genet. 2010;42:420-5.

Biologic effects of simvastatin in patients with aneurysmal subarachnoid hemorrhage - a double-blind, placebo-controlled randomized trial. Vergouwen MDI et al. J Cereb Blood Flow Metab. 2009;29:1444-1453.

Surgical decompression for space-occupying cerebral infarction (the Hemicraniectomy After Middle Cerebral Artery infarction with Life-threatening Edema Trial [HAMLET]): a multicentre, open, randomised trial. Hofmeijer J et al. Lancet Neurol. 2009; 8: 326-33.

The Paracetamol (Acetaminophen) In Stroke (PAIS) trial: a multicentre, randomised, placebo-controlled, phase III trial. Den Hertog HM et al. Lancet Neurol. 2009; 8: 434-40.

To top